Hospital-Acquired Infection Prevention Bundles in Critical Care

 

Hospital-Acquired Infection Prevention Bundles in Critical Care: Evidence-Based Approaches for VAP, CLABSI, and CAUTI

Dr Neeraj Manikath ,Claude.ai

Abstract

Hospital-acquired infections (HAIs) remain a significant cause of morbidity and mortality in critical care settings despite advances in medical care. This review analyzes the evidence supporting prevention bundles for three major HAIs: ventilator-associated pneumonia (VAP), central line-associated bloodstream infections (CLABSI), and catheter-associated urinary tract infections (CAUTI). We evaluate the individual components of these bundles, their collective efficacy, implementation challenges, and strategies to improve adherence. Current evidence strongly supports the use of multimodal prevention bundles that combine evidence-based interventions with robust implementation strategies, leadership engagement, and continuous quality improvement processes. This review provides critical care practitioners with practical guidance on implementing and enforcing these bundles to reduce the burden of HAIs in intensive care units.

Introduction

Hospital-acquired infections (HAIs) constitute a substantial burden in critical care settings, affecting approximately 5-10% of hospitalized patients worldwide and resulting in prolonged hospital stays, increased healthcare costs, and significant mortality. In intensive care units (ICUs), where patients are most vulnerable due to underlying illnesses, invasive devices, and frequent antimicrobial exposure, the incidence and consequences of HAIs are particularly severe. The Centers for Disease Control and Prevention (CDC) estimates that HAIs account for approximately 1.7 million infections and 99,000 associated deaths annually in the United States alone.

Among the most common and preventable HAIs in critical care settings are ventilator-associated pneumonia (VAP), central line-associated bloodstream infections (CLABSI), and catheter-associated urinary tract infections (CAUTI). These device-associated infections represent prime targets for prevention efforts due to their:

1. High prevalence in ICU settings
2. Substantial contribution to patient morbidity and mortality
3. Significant associated healthcare costs
4. Preventable nature through evidence-based interventions

The concept of "bundles"—groupings of evidence-based interventions that, when implemented together, achieve better outcomes than when implemented individually—has revolutionized HAI prevention efforts. First popularized by the Institute for Healthcare Improvement (IHI), bundles typically comprise 3-5 evidence-based practices that, when performed collectively and reliably, have been demonstrated to improve patient outcomes. The bundled approach acknowledges the multifactorial nature of HAIs and addresses the various pathways through which these infections occur.

This review examines the current evidence supporting prevention bundles for VAP, CLABSI, and CAUTI, with particular emphasis on bundle components, implementation strategies, compliance monitoring, and outcomes. We also discuss challenges in bundle implementation and enforcement, as well as strategies to overcome these barriers in critical care settings.

Ventilator-Associated Pneumonia (VAP) Prevention Bundles

Epidemiology and Impact

VAP occurs in 5-40% of mechanically ventilated patients, with variations in reported rates due to differences in diagnostic criteria and surveillance methods. It is associated with prolonged mechanical ventilation (by 4-9 days), extended ICU stays (by 4-13 days), and increased mortality (attributable mortality estimates range from 3-17%). The financial burden is substantial, with additional costs estimated at $40,000-$57,000 per VAP episode.

Evidence-Based VAP Bundle Components

1. Head-of-Bed Elevation (30-45 degrees)

Evidence: Semi-recumbent positioning (30-45 degrees) significantly reduces the risk of aspiration and subsequent pneumonia. A landmark randomized controlled trial by Drakulovic et al. demonstrated a reduction in VAP incidence from 34% to 8% with this intervention alone.

Recommendation: Maintain head-of-bed elevation at 30-45 degrees unless medically contraindicated.

Implementation considerations: Regular monitoring and documentation of head position, visual reminders, and automated bed angle monitors can improve compliance.

2. Daily Sedation Interruption and Assessment for Extubation Readiness

Evidence: Daily interruption of sedative infusions, combined with spontaneous breathing trials, has been shown to reduce duration of mechanical ventilation by 2-4 days and ICU length of stay by 3.5 days.

Recommendation: Implement daily sedation interruption protocols with standardized assessment of extubation readiness.

Implementation considerations: Use of sedation scales (e.g., Richmond Agitation-Sedation Scale), sedation protocols, and daily multidisciplinary rounds focused on ventilator weaning.

3. Oral Care with Chlorhexidine

Evidence: Meta-analyses have shown that oral decontamination with chlorhexidine reduces VAP rates by 40-60%, particularly in cardiac surgery patients. The optimal concentration appears to be 0.12-0.2%.

Recommendation: Perform oral care with chlorhexidine at least twice daily.

Implementation considerations: Standardized oral care kits, clear assignment of responsibility for oral care, and regular documentation.

4. Subglottic Secretion Drainage

Evidence: Continuous or intermittent drainage of subglottic secretions using specialized endotracheal tubes reduces VAP rates by 36-55%.

Recommendation: Use endotracheal tubes with subglottic secretion drainage capability for patients anticipated to require mechanical ventilation for >48-72 hours.

Implementation considerations: Availability of appropriate equipment, staff training, and protocols for drainage frequency and technique.

5. Maintenance of Endotracheal Cuff Pressure

Evidence: Maintaining endotracheal tube cuff pressure between 20-30 cmH2O minimizes micro-aspiration of subglottic secretions while avoiding tracheal injury.

Recommendation: Check and document cuff pressures at least every 8 hours, maintaining pressure between 20-30 cmH2O.

Implementation considerations: Regular monitoring with manometers, staff education on proper measurement techniques, and clear documentation requirements.

6. Early Mobility

Evidence: Early mobilization of mechanically ventilated patients is associated with shorter duration of mechanical ventilation and ICU stay, as well as lower VAP rates.

Recommendation: Implement early progressive mobility protocols for all eligible patients.

Implementation considerations: Multidisciplinary approach involving physicians, nurses, respiratory therapists, and physical therapists; clear criteria for progressing mobility levels.

Efficacy of VAP Bundles

Multiple studies have demonstrated the effectiveness of VAP prevention bundles. A systematic review by Hellyer et al. found that bundle implementation was associated with a 39% reduction in VAP rates (pooled risk ratio 0.61, 95% CI 0.51-0.73). Similarly, a meta-analysis by Ista et al. reported a significant reduction in VAP rates following bundle implementation (pooled OR 0.35, 95% CI 0.23-0.55).

The VAP bundle's efficacy appears to be dependent on high compliance rates. Studies consistently show a dose-response relationship between bundle compliance and VAP reduction. For instance, Bird et al. demonstrated that compliance rates above 95% were associated with significantly lower VAP rates compared to compliance rates below 95%.

Central Line-Associated Bloodstream Infection (CLABSI) Prevention Bundles

Epidemiology and Impact

CLABSIs occur at a rate of 0.8-5.0 per 1,000 central line days in ICUs. Each CLABSI is associated with an attributable mortality of 12-25%, prolonged hospital stay of 7-21 days, and additional healthcare costs of $45,000-$55,000 per episode.

Evidence-Based CLABSI Bundle Components

1. Hand Hygiene

Evidence: Proper hand hygiene before central line insertion and manipulation reduces microbial transmission. The World Health Organization's "Five Moments for Hand Hygiene" emphasizes critical points for hand hygiene in central line care.

Recommendation: Strict adherence to hand hygiene with alcohol-based hand rub or antimicrobial soap before any central line manipulation.

Implementation considerations: Accessible hand hygiene supplies, regular monitoring and feedback, and continuous education.

2. Maximal Sterile Barrier Precautions

Evidence: Use of maximal sterile barriers (cap, mask, sterile gown, sterile gloves, and full-body sterile drape) during central line insertion reduces CLABSI rates by up to 66% compared to standard precautions.

Recommendation: Use maximal sterile barrier precautions for all central line insertions and guidewire exchanges.

Implementation considerations: Availability of complete insertion kits, checklists to ensure compliance, and empowerment of staff to stop procedures if breaches occur.

3. Chlorhexidine Skin Antisepsis

Evidence: Chlorhexidine-alcohol (>0.5% chlorhexidine with alcohol) is superior to povidone-iodine for skin antisepsis, reducing CLABSI rates by approximately 50%.

Recommendation: Use >0.5% chlorhexidine in alcohol solution for skin preparation before central line insertion and during dressing changes.

Implementation considerations: Standardized insertion kits containing chlorhexidine-alcohol, allowing sufficient drying time (>30 seconds), and consideration of contraindications in neonates or patients with allergies.

4. Optimal Catheter Site Selection

Evidence: Subclavian vein placement is associated with lower infection rates compared to internal jugular or femoral sites in adults. Femoral sites should be avoided when possible due to higher infection rates.

Recommendation: Preferentially use the subclavian site for non-tunneled central venous catheters in adults, with consideration of patient-specific factors.

Implementation considerations: Documentation of rationale when non-preferred sites are selected, ultrasound guidance to improve insertion success, and regular assessment of site selection patterns.

5. Daily Review of Catheter Necessity with Prompt Removal

Evidence: The risk of CLABSI increases with duration of catheterization, with unnecessary catheters representing a preventable risk.

Recommendation: Daily assessment of continued need for central lines with prompt removal when no longer essential.

Implementation considerations: Inclusion in daily ICU checklists, clear documentation of indications for continued use, and regular audits of catheter duration.

6. Chlorhexidine-Impregnated Dressings

Evidence: Chlorhexidine-impregnated dressings reduce CLABSI rates by approximately 40-60%, especially in high-risk populations.

Recommendation: Consider use of chlorhexidine-impregnated dressings for central venous catheters, particularly in high-risk patients or units with elevated CLABSI rates despite basic prevention measures.

Implementation considerations: Standardization of dressing types, staff education on application and removal, and monitoring for skin reactions.

Efficacy of CLABSI Bundles

The effectiveness of CLABSI prevention bundles is among the most well-documented successes in HAI prevention. The seminal Michigan Keystone ICU Project demonstrated a 66% reduction in CLABSI rates (from 7.7 to 1.4 per 1,000 catheter days) with bundle implementation across 103 ICUs. This success has been replicated internationally, with studies consistently showing 50-70% reductions in CLABSI rates following bundle implementation.

The Comprehensive Unit-based Safety Program (CUSP) combined with CLABSI bundles has been particularly effective, emphasizing both technical and adaptive (cultural) aspects of prevention. A national implementation of CUSP in over 1,000 U.S. ICUs demonstrated a 43% reduction in CLABSI rates over a 4-year period.

Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Bundles

Epidemiology and Impact

CAUTIs account for approximately 30-40% of all HAIs, with an incidence of 1.5-3.0 infections per 1,000 catheter days in ICUs. While the attributable mortality is lower than for VAP or CLABSI (approximately 2-4%), CAUTIs are associated with increased hospital stays (2-4 days) and costs ($1,200-$4,700 per episode). Additionally, CAUTIs often serve as a reservoir for multidrug-resistant organisms and can lead to secondary bloodstream infections with mortality rates of 10-30%.

Evidence-Based CAUTI Bundle Components

1. Appropriate Urinary Catheter Use

Evidence: 21-55% of urinary catheters placed in hospitalized patients are unnecessary or have inappropriate indications. Limiting catheter use to appropriate indications is the most effective CAUTI prevention strategy.

Recommendation: Insert urinary catheters only for appropriate indications:

• Acute urinary retention or obstruction
• Accurate measurement of urinary output in critically ill patients
• Perioperative use for selected surgeries
• Assistance with healing of open sacral or perineal wounds in incontinent patients
• End-of-life comfort care

Implementation considerations: Requiring physician order with documented indication, use of catheter insertion decision algorithms, and consideration of alternatives (e.g., external catheters, intermittent catheterization).

2. Aseptic Insertion Technique

Evidence: Proper aseptic technique during catheter insertion reduces introduction of pathogens.

Recommendation: Use aseptic insertion technique with sterile equipment and antiseptic cleansing of the meatal area. Only properly trained personnel should insert catheters.

Implementation considerations: Standardized catheter insertion kits, competency verification for inserters, and use of insertion checklists.

3. Maintenance of a Closed Drainage System

Evidence: Maintaining a continuously closed urinary drainage system significantly reduces the risk of CAUTI.

Recommendation: Maintain a closed, unobstructed urinary drainage system. If breaks in asepsis occur, replace the entire system using aseptic technique.

Implementation considerations: Clear protocols for system maintenance, staff education on maintaining closed systems, and prompt replacement when compromised.

4. Proper Catheter Care and Positioning

Evidence: Proper securement and positioning prevent mechanical trauma and urethral colonization.

Recommendation: Secure catheter to prevent movement and urethral traction. Keep collection bag below the level of the bladder at all times but not touching the floor.

Implementation considerations: Use of securement devices, regular positioning checks, and clear guidelines for patient transport.

5. Daily Necessity Assessment with Prompt Removal

Evidence: The risk of CAUTI increases by 3-7% for each day of catheterization. Reminder systems and stop orders reduce catheter duration and CAUTI rates.

Recommendation: Assess need for continued catheterization daily and remove promptly when no longer needed.

Implementation considerations: Nurse-driven removal protocols, electronic reminder systems, catheter removal as part of daily checklists, and regular audits of catheter duration.

Efficacy of CAUTI Bundles

Multiple studies have demonstrated the effectiveness of CAUTI prevention bundles. A systematic review by Meddings et al. found that the use of reminders and stop orders was associated with a 53% reduction in CAUTI rates. The national implementation of the Comprehensive Unit-based Safety Program (CUSP) for CAUTI prevention in over 900 U.S. hospitals demonstrated a 32% reduction in CAUTI rates in non-ICU settings and a 14% reduction in ICU settings.

The efficacy of CAUTI bundles appears to be most significant when focused on reducing inappropriate use and duration of urinary catheters. Strategies that target these aspects, such as nurse-driven removal protocols and electronic order entry systems with automatic stop orders, have shown the greatest impact on CAUTI rates.

Implementation Strategies and Barriers

Key Implementation Strategies

1. Leadership Engagement and Accountability

Successful bundle implementation requires active leadership support at multiple levels:

• Executive leadership: Resource allocation, organizational priority-setting
• Unit leadership: Day-to-day operations, staff accountability
• Clinical champions: Peer influence, technical expertise

Evidence: Units with engaged leadership demonstrate significantly higher bundle compliance and greater reductions in HAI rates.

2. Multidisciplinary Teams

Effective HAI prevention requires collaboration across disciplines, including:

• Physicians
• Nurses
• Respiratory therapists (for VAP)
• Infection preventionists
• Quality improvement specialists
• Pharmacists

Evidence: Multidisciplinary teams improve bundle design, implementation, and sustainability compared to single-discipline approaches.

3. Education and Training

Comprehensive education on bundle components, rationale, and techniques is essential:

• Initial training for all staff
• Periodic refresher education
• Just-in-time training during procedures
• Competency verification

Evidence: Units with comprehensive education programs demonstrate higher compliance rates and superior outcomes.

4. Clear Protocols and Standardization

Standardization reduces variation and improves reliability:

• Procedure-specific checklists
• Standard order sets
• Pre-assembled kits with necessary supplies
• Visual cues and reminders

Evidence: Standardization of processes increases bundle compliance by 20-30% and enhances sustainability.

5. Audit and Feedback Systems

Regular monitoring and feedback are critical:

• Direct observation of practices
• Documentation review
• Process and outcome measures
• Regular feedback to frontline staff
• Transparent reporting of data

Evidence: Units with robust audit and feedback systems demonstrate sustained compliance and continued improvement in HAI rates.

6. Electronic Decision Support and Reminders

Technology can enhance bundle implementation:

• Electronic reminders for catheter/line removal
• Clinical decision support for appropriate device use
• Automated reporting of compliance metrics
• Electronic documentation templates

Evidence: Electronic reminders reduce device utilization by 15-30% and are associated with lower HAI rates.

Common Implementation Barriers

1. Knowledge Barriers

• Lack of awareness of evidence-based practices
• Insufficient understanding of bundle rationale
• Inadequate technical skills

Strategies: Comprehensive education programs, simulation training, competency assessment

2. Attitude Barriers

• Skepticism about bundle effectiveness
• Resistance to changing established practices
• Perception of increased workload

Strategies: Sharing of local success stories, involvement in data collection and analysis, addressing specific concerns

3. Resource Barriers

• Insufficient staffing
• Inadequate equipment or supplies
• Limited time for education and training

Strategies: Executive sponsorship, business case development, process optimization to improve efficiency

4. System Barriers

• Complex workflow processes
• Lack of clear accountability
• Poor communication between disciplines

Strategies: Process mapping and redesign, clear role definition, standardized communication tools

Quality Improvement Methodology in Bundle Implementation

The Model for Improvement

The Institute for Healthcare Improvement's Model for Improvement provides a framework for effective bundle implementation:

1. Setting Aims: Clear, measurable, time-bound goals for HAI reduction
2. Establishing Measures: Process, outcome, and balancing measures
3. Selecting Changes: Evidence-based practices tailored to local context
4. Testing Changes: Using Plan-Do-Study-Act (PDSA) cycles to iterate and improve

Evidence: Units using formal improvement methodology show more rapid and sustained improvements compared to ad hoc implementation approaches.

High-Reliability Organization Principles

Applying high-reliability principles enhances bundle effectiveness:

1. Preoccupation with failure: Analyzing near-misses and process deviations
2. Reluctance to simplify: Understanding the complex nature of HAIs
3. Sensitivity to operations: Awareness of real-time compliance with bundle elements
4. Commitment to resilience: Rapid identification and correction of problems
5. Deference to expertise: Valuing input from frontline staff regardless of hierarchy

Evidence: Organizations applying high-reliability principles demonstrate superior sustainability of HAI prevention efforts.

Measuring Success: Process and Outcome Metrics

Process Measures

Process measures assess the reliable delivery of bundle components:

1. Compliance rate: Percentage of bundle elements performed correctly (all-or-none measurement)
2. Device utilization ratio: Device days / patient days
3. Insertion practice adherence: Compliance with insertion-specific elements
4. Maintenance practice adherence: Compliance with daily care elements

Recommendation: Monitor both overall bundle compliance and individual element compliance to identify specific areas for improvement.

Outcome Measures

Outcome measures assess the impact of bundle implementation:

1. Infection rates: Number of infections per 1,000 device days
2. Standardized infection ratio (SIR): Observed infections / predicted infections
3. Length of stay: Impact on ICU and hospital length of stay
4. Mortality: Changes in attributable and overall mortality
5. Cost: Financial impact of HAI reduction

Recommendation: Use risk-adjusted measures when possible and monitor unintended consequences.

Sustaining Success: Beyond Initial Implementation

Strategies for Sustainability

1. Hardwiring changes: Embedding bundle elements in standard workflows and documentation
2. Continuous monitoring: Ongoing surveillance of process and outcome measures
3. Regular feedback: Continued sharing of data with frontline staff
4. Refresher training: Periodic education to address staff turnover and skill decay
5. Celebrating success: Recognizing achievements to maintain motivation
6. Adapting to emerging evidence: Updating bundles as new evidence emerges

Evidence: Units employing specific sustainability strategies maintain 85-95% of initial gains compared to 50% in units without such strategies.

Common Challenges to Sustainability

1. Initiative fatigue: Multiple competing quality initiatives
2. Leadership turnover: Loss of key champions
3. Resource constraints: Reduction in dedicated resources after initial success
4. Complacency: Decreased vigilance following initial improvements
5. Changing priorities: Shift in organizational focus

Strategies: Integration into routine operations, succession planning, business case for continued investment, regular reassessment of bundle relevance

Future Directions

Emerging Technologies

1. Electronic surveillance systems: Automated detection of HAIs and compliance monitoring
2. Novel antimicrobial materials: Device coatings and impregnated materials
3. Point-of-care diagnostics: Rapid identification of colonization and infection
4. Predictive analytics: Risk stratification and targeted prevention strategies

Research Priorities

1. Bundle optimization: Identifying the most effective bundle components
2. Implementation science: Understanding barriers and facilitators to reliable implementation
3. Personalized prevention: Tailoring interventions based on patient risk factors
4. Cost-effectiveness: Determining the economic impact of different prevention strategies
5. Behavioral science: Applying behavioral insights to improve compliance

Conclusion

HAI prevention bundles represent one of the most successful applications of evidence-based medicine in critical care. The bundled approach to VAP, CLABSI, and CAUTI prevention has demonstrated consistent efficacy across diverse healthcare settings, with substantial reductions in infection rates, morbidity, mortality, and costs.

The success of bundle implementation depends not only on the selection of evidence-based interventions but also on the quality of implementation, contextual adaptation, leadership support, and sustainability planning. By combining technical interventions with attention to cultural and behavioral factors, healthcare organizations can achieve substantial and sustained reductions in HAI rates.

Critical care practitioners play a pivotal role in HAI prevention as both implementers of daily practices and champions for system-level changes. By understanding the evidence behind bundle components and the principles of effective implementation, clinicians can contribute significantly to improved patient outcomes and safety in critical care settings.

References

1. Klompas M, Branson R, Eichenwald EC, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(8):915-936.

2. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-e193.

3. Gould CV, Umscheid CA, Agarwal RK, et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010;31(4):319-326.

4. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.

5. Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999;354(9193):1851-1858.

6. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.

7. Klompas M, Li L, Kleinman K, et al. Associations between ventilator bundle components and outcomes. JAMA Intern Med. 2016;176(9):1277-1283.

8. Saint S, Greene MT, Krein SL, et al. A program to prevent catheter-associated urinary tract infection in acute care. N Engl J Med. 2016;374(22):2111-2119.

9. Ista E, van der Hoven B, Kornelisse RF, et al. Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(6):724-734.

10. Meddings J, Rogers MA, Krein SL, et al. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review. BMJ Qual Saf. 2014;23(4):277-289.

11. Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753-771.

12. Hellyer TP, Ewan V, Wilson P, Simpson AJ. The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. J Intensive Care Soc. 2016;17(3):238-243.

13. Saint S, Fowler KE, Sermak K, et al. Program to prevent catheter-associated urinary tract infection: HAI reduction initiative. AHRQ Publication No. 15-0073-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2015.

14. Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186(12):1272-1278.

15. Weaver SJ, Lubomksi LH, Wilson RF, et al. Promoting a culture of safety as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5 Pt 2):369-374.

16. Krein SL, Damschroder LJ, Kowalski CP, et al. The influence of organizational context on quality improvement and patient safety efforts in infection prevention: a multi-center qualitative study. Soc Sci Med. 2010;71(9):1692-1701.

17. Septimus E, Yokoe DS, Weinstein RA, et al. Maintaining the momentum of change: the role of the 2014 updates to the compendium in preventing healthcare-associated infections. Infect Control Hosp Epidemiol. 2014;35(5):460-463.

18. Zingg W, Holmes A, Dettenkofer M, et al. Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis. 2015;15(2):212-224.

19. Klompas M, Anderson D, Trick W, et al. The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med. 2015;191(3):292-301.

20. Furuya EY, Dick A, Perencevich EN, et al. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One. 2011;6(1):e15452.